Wilson Sonsini Goodrich & Rosati advised Cytovale on intellectual property strategy generally and advised the company on IP matters related to the transaction. Cytovale, a commercial-stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aspect Biosystems on the transaction. Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, and leading global...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Replay on the deal. Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced its launch with $55 million...
You must be a Standard 1 Year member to access this content.
